EP4026540A1 — A film coated tablet comprising apixaban
Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2022-07-13 · 4y expired
What this patent protects
The present invention relates to a film coated tablet comprising apixaban and at least one binder, wherein at least one binder is dissolved in solvent comprising water. Furthermore, the present invention discloses a process for the preparation of a film coated tablet formulation …
USPTO Abstract
The present invention relates to a film coated tablet comprising apixaban and at least one binder, wherein at least one binder is dissolved in solvent comprising water. Furthermore, the present invention discloses a process for the preparation of a film coated tablet formulation comprising apixaban. The process is simple, rapid, cost effective, time-saving and industrially convenient process and is created to eliminate the disadvantages of active ingredient.
Drugs covered by this patent
- Eliquis (apixaban) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.